Steve Potts: Policy Headwinds Are Reshaping Biotech Financing
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Steve Potts, CEO of Breakthru Medicine, to discuss how biotech financing, drug pricing policy, scientific infrastructure, and public trust are reshaping oncology innovation and U.S. biopharma leadership.
Key Topics:
Biotech Financing: Series A funding, early-stage platform headwinds, clinical asset momentum, academic funding strain.
Small Molecule Shift: IRA incentives, NDA versus BLA timelines, oncology pipeline pullbacks, antibody drug conjugates.
Orphan Cures and EPIC Acts: Orphan Cures Act, EPIC Act, patent…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.